SZLSStageZero Life Sciences Ltd.
0.0400CAD0.00%Mkt Cap: 3.60M $P/E: —35d ago
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap3.60M $
Enterprise Value—
Revenue (TTM)—
Gross Profit-294.03K $
Net Income (TTM)-8.31M $
Revenue/Share—
Last Price0.0400 CAD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.44
EPS (TTM)—
EPS (Forward)—
52W Range
—
52W High0.0400 CAD
52W Low0.0400 CAD
Profitability
Gross Margin-10.64%
Oper. Margin—
EBITDA Margin—
Profit Margin-300.79%
ROE152.14%
ROA-1629.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.57M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.24
Current Ratio—
Quick Ratio—
Book Value/Sh-0.0900 CAD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateSep 18, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.123.53M
Float—
Insiders—
Institutions—
Technical
SMA 500.0400 (-0.0%)
SMA 2000.0400 (-0.0%)
Beta—
S&P 52W Chg—
Avg Vol (30d)0
Avg Vol (10d)—
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0400 CAD
BB Middle0.0400 CAD
BB Lower0.0400 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—